AstraZeneca Canada is the Canadian affiliate of AstraZeneca plc—a science-led pharmaceutical and biotechnology company. With over 2,400 employees nationwide and a growing Mississauga R&D hub, they lead in global clinical trials and innovative medicine development in areas such as oncology, cardiovascular, respiratory, and immunology. Their recent C$820 million investment underscores their strong commitment to expanding Canadian clinical research capacity and production capabilities.